Introduction to Unaudited Pro Forma Combined Financial StatementsForma Combined Financial Statements • August 21st, 2019 • Health Insurance Innovations, Inc. • Insurance agents, brokers & service
Contract Type FiledAugust 21st, 2019 Company IndustryOn June 5, 2019, the Health Insurance Innovations, Inc. (the “Company” or “HIIQ”) entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with RxHelpline, LLC (“RXH”), TogetherHealth PAP, LLC (“THP”), TogetherHealth Insurance, LLC (“THI” and, collectively with RXH and THP, “TogetherHealth”), TogetherHealth Soup, L.P. (“Seller”) and certain principals of TogetherHealth, pursuant to which Health Plan Intermediaries Holdings, LLC, a consolidated subsidiary of HIIQ, purchased 100% of the outstanding limited liability company interests of TogetherHealth (the “Interests”). The closing of the transactions contemplated by the Purchase Agreement occurred on June 5, 2019, simultaneous with the signing of the Purchase Agreement.
UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTSForma Combined Financial Statements • December 12th, 2023 • MDWerks, Inc. • Blank checks
Contract Type FiledDecember 12th, 2023 Company IndustryThe following unaudited pro forma combined financial data are presented to illustrate the effect of the following merger agreement (the “Merger”): On February 13, 2023, MDwerks, Inc. (the “Company”) entered into a Merger Agreement (the “Merger Agreement”), by and between the Company, MD-TT Merger Sub, Inc., a wholly owned subsidiary of the Company (“Merger Sub”) and Two Trees Beverage Co. (“Two Trees”). The Merger Agreement was amended on February 16, 2023, September 11, 2023 and December 7, 2023. The Company, Merger Sub and Two Trees may be referred to herein collectively as the “Parties” and separately as a “Party.” The Merger closed on December 8, 2023.
Lexicon Pharmaceuticals, Inc. Unaudited Pro Forma Combined Financial StatementsForma Combined Financial Statements • March 16th, 2011 • Lexicon Pharmaceuticals, Inc./De • Pharmaceutical preparations
Contract Type FiledMarch 16th, 2011 Company IndustryOn July 30, 2010, Lexicon Pharmaceuticals, Inc. (“Lexicon”) entered into an amended and restated purchase option agreement (the “Amended and Restated Purchase Option Agreement”) with Symphony Icon Holdings LLC (“Holdings”) and Symphony Icon, Inc. (“Symphony Icon”), amending and restating its purchase option agreement with Holdings and Symphony Icon dated June 15, 2007.
UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTSForma Combined Financial Statements • December 23rd, 2020 • Advanced Container Technologies, Inc. • Miscellaneous plastics products
Contract Type FiledDecember 23rd, 2020 Company IndustryThe Company entered into an Exchange Agreement, dated as of August 14, 2020, by and among the Company, Advanced Container Technologies, Inc., a California corporation (“ACT”), and all of the shareholders of ACT (the “Shareholders”), which was amended on September 9, 2020 (as amended, the “Exchange Agreement”). The closing under the Exchange Agreement occurred on October 9, 2020, such that the Shareholders exchanged, on a pro rata basis, all of their shares in ACT for 50,000,000 shares of the Company’s common stock (the “Exchange”). As a result of the Exchange, ACT became the wholly owned subsidiary of the Company. The Company changed its corporate name to Advanced Container Technologies, Inc. on October 3, 2020.
UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTSForma Combined Financial Statements • May 24th, 2024 • MDWerks, Inc. • Beverages
Contract Type FiledMay 24th, 2024 Company IndustryThe following unaudited pro forma combined financial data are presented to illustrate the effect of the following acquisitions (“the Acquisitions”):
Introduction to Unaudited Pro Forma Combined Financial StatementsForma Combined Financial Statements • September 29th, 2014 • Health Insurance Innovations, Inc. • Insurance agents, brokers & service
Contract Type FiledSeptember 29th, 2014 Company Industry